论文部分内容阅读
血管内皮生长因子(VEGF)、p53蛋白表达是非小细胞肺癌重要的不良预后因素,而且与其化学治疗(化疗)疗效相关[1-3]。本研究应用免疫组织化学(组化)方法检测化疗前非小细胞肺癌组织VEGF、p53蛋白的表达,探讨其对术前化疗的Ⅲa期非小细胞肺癌患者生存率的影响。资料与方法1.研究对?
Vascular endothelial growth factor (VEGF), p53 protein expression is an important adverse prognostic factor for non-small cell lung cancer, and its chemotherapy (chemotherapy) efficacy [1-3]. In this study, immunohistochemistry (IHC) was used to detect the expression of VEGF and p53 protein in non-small cell lung cancer (NSCLC) before chemotherapy and to investigate the effect on the survival rate of patients with stage Ⅲa non-small cell lung cancer before operation. Data and methods 1. Research?